文献速递创伤与烧伤复苏、休克与脓毒症重症综合管理与镇静镇痛

更早达到止血与死亡率及并发症发生率降低相关:来自务实随机最佳血小板与血浆比例试验的结果

Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trial.
PubMed 文献 · J Trauma Acute Care Surg · 2019-01-01
一句话结论在出血创伤患者中,止血时间每缩短15分钟,30天死亡率、急性肾损伤、急性呼吸窘迫综合征、多器官衰竭和脓毒症发生率均独立降低。

该研究基于务实随机最佳血小板与血浆比例试验的前瞻性数据,纳入680例患者中468例(69%)在90分钟内接受急诊手术或介入放射操作者,分析止血时间与结局的关系。在408例(87%)实现止血的患者中,止血时间每减少15分钟,30天死亡率(RR 0.97;95%CI 0.94-0.99)、急性肾损伤(RR 0.97;95%CI 0.96-0.98)、急性呼吸窘迫综合征(RR 0.98;95%CI 0.97-0.99)、多器官衰竭(RR 0.94;95%CI 0.91-0.97)和脓毒症(RR 0.98;95%CI 0.96-0.99)均降低,静脉血栓栓塞无显著关联。作者认为止血时间应作为创伤研究终点和潜在质量指标。

要点

  • 在408例实现止血的出血创伤患者中,止血时间每减少15分钟,30天死亡率降低(RR 0.97;95%CI 0.94-0.99)。
  • 止血时间每减少15分钟,急性肾损伤(RR 0.97;95%CI 0.96-0.98)和急性呼吸窘迫综合征(RR 0.98;95%CI 0.97-0.99)发生率降低。
  • 止血时间每减少15分钟,多器官衰竭(RR 0.94;95%CI 0.91-0.97)和脓毒症(RR 0.98;95%CI 0.96-0.99)发生率降低。
  • 止血时间与静脉血栓栓塞无显著关联(RR 0.99;95%CI 0.96-1.03)。
  • 作者认为止血时间应作为创伤研究终点和潜在质量指标。

适用人群与场景

  • 来自务实随机最佳血小板与血浆比例试验的前瞻性数据,纳入680例患者中468例(69%)在90分钟内接受急诊手术室或介入放射操作者。

诊断标准与关键阈值

  • 止血 predefined 为手术野无需要干预的术中出血或介入放射学对比剂 blush 消退。

研究设计与关键结果

  • 研究类型为对务实随机最佳血小板与血浆比例试验前瞻性数据的分析,680例入组患者中468例(69%)接受急诊操作,408例(87%)实现止血。
  • 止血时间减少的患者损伤严重度更低、入院碱剩余紊乱更轻、钝性创伤比例更低(均 p < 0.05)。
  • 在408例实现止血的患者中,止血时间每减少15分钟与30天死亡率降低相关(RR 0.97;95%CI 0.94-0.99)。
  • 止血时间每减少15分钟与急性肾损伤降低相关(RR 0.97;95%CI 0.96-0.98)。
  • 止血时间每减少15分钟与急性呼吸窘迫综合征降低相关(RR 0.98;95%CI 0.97-0.99)。
  • 止血时间每减少15分钟与多器官衰竭降低相关(RR 0.94;95%CI 0.91-0.97)。
  • 止血时间每减少15分钟与脓毒症降低相关(RR 0.98;95%CI 0.96-0.99)。
  • 止血时间与静脉血栓栓塞无显著关联(RR 0.99;95%CI 0.96-1.03)。

证据类型、等级与局限

  • 证据类型为对随机试验前瞻性数据的分析,证据等级为治疗/临床管理 level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为止血时间应作为创伤研究终点和潜在质量指标。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKDROP: Clinicians intuitively recognize that faster time to hemostasis is important in bleeding trauma patients, but these times are rarely reported.

METHODS: Prospectively collected data from the Pragmatic Randomized Optimal Platelet and Plasma Ratios trial were analyzed. Hemostasis was predefined as no intraoperative bleeding requiring intervention in the surgical field or resolution of contrast blush on interventional radiology (IR). Patients who underwent an emergent (within 90 minutes) operating room (OR) or IR procedure were included. Mixed-effects Poisson regression with robust error variance (controlling for age, Injury Severity Score, treatment arm, injury mechanism, base excess on admission [missing values estimated by multiple imputation], and time to OR/IR as fixed effects and study site as a random effect) with modified Bonferroni corrections tested the hypothesis that decreased time to hemostasis was associated with decreased mortality and decreased incidence of acute kidney injury (AKI), acute respiratory distress syndrome (ARDS), multiple-organ failure (MOF), sepsis, and venous thromboembolism.

RESULTS: Of 680 enrolled patients, 468 (69%) underwent an emergent procedure. Patients with decreased time to hemostasis were less severely injured, had less deranged base excess on admission, and lower incidence of blunt trauma (all p < 0.05). In 408 (87%) patients in whom hemostasis was achieved, every 15-minute decrease in time to hemostasis was associated with decreased 30-day mortality (RR, 0.97; 95% confidence interval [CI], 0.94-0.99), AKI (RR, 0.97; 95% CI, 0.96-0.98), ARDS (RR, 0.98; 95% CI, 0.97-0.99), MOF (RR, 0.94; 95% CI, 0.91-0.97), and sepsis (RR, 0.98; 95% CI, 0.96-0.99), but not venous thromboembolism (RR, 0.99; 95% CI, 0.96-1.03).

CONCLUSION: Earlier time to hemostasis was independently associated with decreased incidence of 30-day mortality, AKI, ARDS, MOF, and sepsis in bleeding trauma patients. Time to hemostasis should be considered as an endpoint in trauma studies and as a potential quality indicator.

LEVEL OF EVIDENCE: Therapeutic/care management, level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Chang R, Kerby JD, Kalkwarf KJ, et al. Earlier time to hemostasis is associated with decreased mortality and rate of complications: Results from the Pragmatic Randomized Optimal Platelet and Plasma Ratio trial. J Trauma Acute Care Surg. 2019. PMID: 31349348. doi:10.1097/TA.0000000000002263

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。